The Dodgers are counting on Max Muncy to be ready to produce in October.
As they should.
Muncy is expected to be sidelined for six weeks with a bone bruise in his left knee but that won’t push them into the market for another third baseman between now and the July 31 trade deadline.
“I don’t think that changes much, knowing the certainty of Max coming back at some point,” manager Dave Roberts said.
The faith in Muncy is justified by his track record, the former All-Star missing three months last year but setting an all-time playoff record by reaching base in 12 consecutive plate appearances on the team’s World Series run.
This doesn’t mean the Dodgers shouldn’t be looking to strike a major deal over the next three-plus weeks.
They still have to address their greatest obstacle to become their sport’s repeat champions in 25 years. They still have to address their starting pitching.
Every sign points to the Dodgers taking a passive approach in dealing with the issue, as they continue to point to the anticipated returns of Tyler Glasnow and Blake Snell.
Glasnow pitched 4 ⅓ innings for triple-A Oklahoma City on Thursday and Roberts said he expected the 6-foot-8 right-hander to rejoin the rotation on the Dodgers’ upcoming trip to Milwaukee and San Francisco.
Dodgers pitcher Tyler Glasnow throws in the outfield before a game against the New York Mets at Dodger Stadium on June 4.
(Gina Ferazzi/Los Angeles Times)
Snell pitched to hitters in live batting practice on Wednesday and is scheduled to do so again on Saturday. The left-hander could be on a minor-league rehabilitation assignment by next week.
Glasnow and Snell are former All-Stars, but how much can the Dodgers rely on them?
Unironically nicknamed “Glass,” Glasnow hasn’t pitched since April. The $136.5-million man has never pitched more than the 134 innings he pitched last year, and even then, he wasn’t unavailable for the playoffs.
Snell made just 20 starts last year with the San Francisco Giants but was signed by the Dodgers to a five-year, $182-million contract over the winter. He made only two starts for them before he was placed on the injured list with shoulder inflammation.
Dodgers pitcher Blake Snell throws the ball against the Atlanta Braves at Dodger Stadium on April 2.
(Robert Gauthier/Los Angeles Times)
Ideally, the Dodgers’ postseason rotation would consist of Yoshinobu Yamamoto, Snell, Glasnow and Shohei Ohtani. There’s no guarantee that will materialize, considering that Yamamoto and Ohtani have their own complicated medical histories.
Yamamoto pitched heroically in the playoffs last year but only after missing three months in the regular season. Ohtani returned from his second elbow reconstruction last month but has been used as an opener so far. Ohtani is expected to pitch two innings on Saturday against the Houston Astros, and the team doesn’t envision using him for more than four or five innings at a time in the playoffs.
Every pitcher is an injury risk, and the Dodgers know that. But just because they won the World Series last year with three starting pitchers — they resorted to bullpen games when Yamamoto, Jack Flaherty and Walker Buehler couldn’t pitch — doesn’t mean they can lean as heavily on their relievers and expect the same results. The approach has resulted in more postseason disappointments than championships, so much so that when Ohtani was being recruited by the Dodgers before last season, Mark Walter told him he considered his previous 12 years of ownership to be a failure.
Ohtani will celebrate his 31st birthday on Saturday. He might not be showing his age yet, but Freddie Freeman and Mookie Betts have. Freeman will be 36 in September and Betts 33 in October. The window in which the Dodgers have three MVP-caliber players in the lineup is closing, which should inspire a sense of urgency.
The front office’s reluctance to shop in a seller’s market is understandable, considering the most attractive possibilities are by no means sure things. Chris Sale of the Atlanta Braves is on the 60-day injured list with a fractured rib. Sandy Alcantara of the Miami Marlins has been up and down in his return from Tommy John surgery. Then again, the Dodgers made a smart buy in Flaherty last year and the gamble resulted in a World Series.
At this point, it’s up to Glasnow and Snell to perform well enough to convince the Dodgers they don’t need any more pitching. Until Glasnow and Snell do that, the team should operate as if it has to do something.
